📰 Co Diagnostics News
Page 9 - Co Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Co Diagnostics. Real-time updates on events, politics, business and more.
March 22, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
March 17, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
March 17, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
March 15, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
March 15, 2022
Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase Program Salt Lake City, Utah - March 15, 2022 - Co-Diagnostics, Inc. , a molecular diagnostics... | March 15, 2022
March 15, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
March 14, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
February 10, 2022
/PRNewswire/ -- The "Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With COVID-19 Impact & Forecasting/Analysis, and...
February 10, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
February 10, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...